SCHEMBL3136909

SCHEMBL3136909

CC1CCN(c2ccc(Nc3cncc(-c4ccccn4)n3)nc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 9/20 0.42
CCND1 P24385 4/20 0.42
CDK1 P06493 3/20 0.42
CCNB1 P14635 3/20 0.42
FLT3 P36888 3/20 0.42
CDK6 Q00534 6/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ACHE P22303 1/20 0.39
CCNE1 P24864 2/20 0.38
CDK2 P24941 2/20 0.38
HSF1 Q00613 1/20 0.38
EGFR P00533 3/20 0.38
SLC2A1 P11166 1/20 0.38
CCND3 P30281 2/20 0.37
CCNK O75909 1/20 0.37
CDK9 P50750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3138726 0.89 CCNA2 (0.43) CDK4CCND1CDK1CDK6CCNE1
SCHEMBL3137902 0.88 CDK6 (0.49) CDK4CCND1CDK1FLT3CDK6
Hydrochloric Acid SCHEMBL3147026 0.88 CCNA2 (0.42) CDK4CCND1CDK1CDK6CCNE1
SCHEMBL3128560 0.88 CCNA2 (0.44) CDK4CCND1CDK6NPC1MAPT
Hydrochloric Acid SCHEMBL3158986 0.87 CDK6 (0.48) CDK4CCND1CDK1FLT3CDK6
Hydrochloric Acid SCHEMBL3143181 0.87 CCNA2 (0.44) CDK4CCND1CDK6NPC1MAPT
SCHEMBL3137946 0.86 CYP1A1 (0.48) CDK4CCND1CDK6NPC1GAA
Hydrochloric Acid SCHEMBL3134638 0.85 CYP1A1 (0.47) CDK4CCND1CDK6NPC1GAA
Hydrochloric Acid SCHEMBL6368427 0.81 SLC2A1 (0.60) NPC1MAPTRAB9ASMN1; SMN2SLC2A1
SCHEMBL2820000 0.78 TRPM8 (0.55) MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742935-B1 POLYCYCLIC PYRAZINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN INC (US) 2010-02-24 EP claimed
US-7642354-B2 Use treating nervous system disorders, as neuroprotectants, gastrointestinal disorders, cardiovascular disorders; e.g. 2-(5-phenylpyridin-2-ylamino)-6-pyridin-2-ylpyrimidine ICAGEN, INC. (US) 2010-01-05 US claimed
EP-1742935-B1 POLYCYCLIC PYRAZINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN INC (US) 2010-02-24 EP disclosed